Skip to main content
Premium Trial:

Request an Annual Quote

Hoping for Quicker Results

Quickly and cheaply is the goal of Pathogenica, a start-up that proposes to diagnose diseases using sequencing technology, reports MIT's Technology Review. By the end of 2012, the company hopes to have an FDA-approved product to detect the bacteria behind urinary tract infections, all for $10 a test. "The majority [of current tests] require days to get a result, which is frequently too late," says Columbia University's Ian Lipkin, who is on Pathogenica's board, to Tech Review.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.